Dr. Francesca Cottini discusses her research on monoclonal gammopathy of renal significance (MGRS) and its treatment with novel therapies. The study evaluates real-world data, highlighting the effectiveness of clone-directed therapies in improving survival, while also addressing the challenge of disease relapse and the need for further research into new therapeutic targets.

Link to ASH playlist: [ Ссылка ]

ASH Abstract: Real-World Outcomes of Monoclonal Gammopathy of Renal Significance (MGRS) in the Era of Novel Therapies
#ASH24 #myeloma #mmsm

Follow HealthTree:
[ Ссылка ]
twitter.com/healthtreeformm
facebook.com/healthtreeformultiplemyeloma
instragram.com/healthtreeformultiplemyeloma

свернуть